This is a proof (draft) Hansard, not the final version.

The Parliament has not yet published the final text for this day, so the wording, who said what and the results of divisions may change.

Senate debates Bills

Therapeutic Goods Amendment (Medicines Shortages and Other Measures) Bill 2026, Therapeutic Goods (Charges) Amendment Bill 2026; Second Reading


Charlotte Walker

Charlotte Walker SA, Australian Labor Party

7:31 pm

Most Australians probably don't spend much time thinking about medicines supply chains—and why should they? By all economic norms of globalisation, these aren't concerns that should live rent free in our minds. But, as we've seen in the past 12 months, when global supply chains get disrupted the knock-on effects spread to far-reaching places. For most Aussies, when they go to the pharmacy with a prescription they should expect it to be filled. They expect that the medicine their doctor has prescribed will be available and affordable, and that they will get it on the day. These are normal and reasonable expectations in a developed country like Australia.

But we know that, for a growing number of Australians, this isn't the reality anymore. We've seen shortages of ADHD medication, hormone replacement therapies, contraceptive pills, diabetes medication and even IV fluids. These are medications used by thousands of Australians every day that they rely on to manage chronic conditions, to maintain their health and, in many cases, to stay alive. When these medications suddenly become unavailable, the consequences can be devastating. For someone managing ADHD, it can mean weeks of struggling to concentrate at work or university. For a woman going through menopause, it might mean being unable to access hormone replacement therapy that has finally made her symptoms manageable. For someone with a serious chronic illness, it could mean having to change treatment that has taken years to get right. For healthcare workers, it means spending valuable time trying to find alternatives, contacting suppliers, rewriting prescriptions and reassuring understandably frustrated patients. None of this is good enough, and that's why the Albanese Labor government is taking further action to strengthen Australia's medicines supply chain.

The Therapeutic Goods (Charges) Amendment Bill 2026 and the Therapeutic Goods Amendment (Medicines Shortages and Other Measures) Bill 2026 are about making our medicines system more responsive, more transparent and better equipped to deal with shortages before they become full-blown crises. While Australia can't control every disruption to global medicines supply chains, we can absolutely improve how we prepare for them and respond when things go wrong. We as a country are particularly vulnerable to these kinds of disruptions. We're a relatively small market, geographically isolated and heavily dependent on medicines manufactured overseas. A manufacturing problem on the other side of the world, a shipping disruption or an unexpected surge in demand can quickly become a problem for Australian patients. These problems aren't always predictable, but we can make sure that, when a pharmaceutical company knows that a medicine is going to become unavailable, the people responsible for managing that shortage find out as early as possible. This is one of the central purposes of this legislation. Currently, pharmaceutical sponsors are required to notify the TGA when they decide to permanently discontinue a medicine, but the supporting requirements differ depending on whether discontinuation is considered critical. For critical medications, 12 months notice is needed, but for other medication only six months is deemed necessary. This bill simplifies this system and means that sponsors will be required to give 12 months notice of planned discontinuation for all reportable medicines. This six-month difference can be huge. Time flies quickly when you're scrambling to identify alternative suppliers, arrange new stock, advise healthcare professionals and make sure patients aren't left without treatment. Giving the TGA more warning means giving our health system more time to act.

The Albanese Labor government are proud of their long tradition of building, supporting and maintaining the healthcare system in Australia, and this legislation is a continuation of that investment into our health services. That has always been at the heart of Labor's approach to health care. Access is about more than affordability. There is little comfort in having a prescription subsidised through the PBS if the medicine is not available when you need it, and that's why these reforms matter. They are part of the practical work of maintaining and strengthening our healthcare system, ensuring Australians can have confidence that, when they need treatment, the system is better equipped to deliver it. The Albanese Labor government understands that protecting Medicare means looking after the entire healthcare system. It means making medicines more affordable through the PBS, strengthening bulk-billing, investing in the health workforce and ensuring Australians can access care closer to home. It also means making sure our health system has the information and tools it needs to respond to medicines shortages before patients feel the impact. No government can prevent every supply disruption, but we can make sure Australia's health system is better prepared, better informed and focused on protecting patients. Ultimately, these reforms reflect a principle that has guided Labor governments for generations: that Australians deserve a healthcare system that they can trust, and that access to essential treatment should never be taken for granted.

Comments

No comments